Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Knoll Capital Management, Lp Insider Profile
4 Followers
Knoll Capital Management, Lp, Ten Percent Owner at Corbus Pharmaceuticals, holds 2.75M shares in Corbus Pharmaceuticals (Ticker: CRBP), holds 0.00 shares in Medivation (Ticker: MDVN). Most recently, Knoll Capital Management, Lp Bought ― shares of Corbus Pharmaceuticals on Aug 04, 2015 for an estimated value of ―.
Knoll Capital Management, Lp has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Knoll Capital Management, Lp does not currently own shares as a corporate insider.
A breakdown of Knoll Capital Management, Lp's holdings
Insider Roles
Ten Percent Owner
Roles that Knoll Capital Management, Lp holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Knoll Capital Management, Lp
Knoll Capital Management, Lp's Trading History
Corbus Pharmaceuticals
Aug 04, 2015
Ten Percent Owner
Informative Buy
―
$23.82M
Medivation
―
―
―
$0.00
List of latest transactions for each holding click on a transaction to see Knoll Capital Management, Lp's performance on stock
You May Also Like
Knoll Capital Management, Lp insider profile FAQ
What is the percentage of profitable transactions made by Knoll Capital Management, Lp?
The percentage of profitable transactions made by Knoll Capital Management, Lp is ―.
What is the average return per transaction made by Knoll Capital Management, Lp?
The average return per transaction made by Knoll Capital Management, Lp is ―.
What stocks does Knoll Capital Management, Lp hold?
Knoll Capital Management, Lp holds: CRBP, MDVN stocks.
What was Knoll Capital Management, Lp’s latest transaction?
Knoll Capital Management, Lp latest transaction was an Informative Buy of ―.
What was Knoll Capital Management, Lp's most profitable transaction?
Knoll Capital Management, Lp’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Knoll Capital Management, Lp's role in Corbus Pharmaceuticals?
Knoll Capital Management, Lp's role in Corbus Pharmaceuticals is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.